Due to necessary maintenance, Xenbase will be unavailable December 24-30, 2014. We apologize for the inconvenience.

Click on this message to dismiss it.
Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-8893
J Biol Chem. August 17, 2001; 276 (33): 30794-802.

Molecular basis of calmodulin tethering and Ca2+-dependent inactivation of L-type Ca2+ channels.

Pitt GS , Z├╝hlke RD , Hudmon A , Schulman H , Reuter H , Tsien RW .


Abstract
Ca(2+)-dependent inactivation (CDI) of L-type Ca(2+) channels plays a critical role in controlling Ca(2+) entry and downstream signal transduction in excitable cells. Ca(2+)-insensitive forms of calmodulin (CaM) act as dominant negatives to prevent CDI, suggesting that CaM acts as a resident Ca(2+) sensor. However, it is not known how the Ca(2+) sensor is constitutively tethered. We have found that the tethering of Ca(2+)-insensitive CaM was localized to the C-terminal tail of alpha(1C), close to the CDI effector motif, and that it depended on nanomolar Ca(2+) concentrations, likely attained in quiescent cells. Two stretches of amino acids were found to support the tethering and to contain putative CaM-binding sequences close to or overlapping residues previously shown to affect CDI and Ca(2+)-independent inactivation. Synthetic peptides containing these sequences displayed differences in CaM-binding properties, both in affinity and Ca(2+) dependence, leading us to propose a novel mechanism for CDI. In contrast to a traditional disinhibitory scenario, we suggest that apoCaM is tethered at two sites and signals actively to slow inactivation. When the C-terminal lobe of CaM binds to the nearby CaM effector sequence (IQ motif), the braking effect is relieved, and CDI is accelerated.

PubMed ID: 11408490
Article link: J Biol Chem.
Grant support: GM58234 NIGMS NIH HHS , K08 HL003743-03 NHLBI NIH HHS , K08 HL003743-03 NHLBI NIH HHS , K08 HL003743-03 NHLBI NIH HHS , K08 HL003743-03 NHLBI NIH HHS , K08 HL003743-03 NHLBI NIH HHS , K08 HL003743-03 NHLBI NIH HHS , K08 HL003743-04 NHLBI NIH HHS , K08 HL003743-04 NHLBI NIH HHS , K08 HL003743-04 NHLBI NIH HHS , K08 HL003743-04 NHLBI NIH HHS , K08 HL003743-04 NHLBI NIH HHS , K08 HL003743-04 NHLBI NIH HHS , K08 HL003743-05 NHLBI NIH HHS , K08 HL003743-05 NHLBI NIH HHS , K08 HL003743-05 NHLBI NIH HHS , K08 HL003743-05 NHLBI NIH HHS , K08 HL003743-05 NHLBI NIH HHS , K08 HL003743-05 NHLBI NIH HHS , K08 HL003743-06 NHLBI NIH HHS , K08 HL003743-06 NHLBI NIH HHS , K08 HL003743-06 NHLBI NIH HHS , K08 HL003743-06 NHLBI NIH HHS , K08 HL003743-06 NHLBI NIH HHS , K08 HL003743-06 NHLBI NIH HHS , K08 HL03743 NHLBI NIH HHS , K08 HL03743 NHLBI NIH HHS , K08 HL03743 NHLBI NIH HHS , K08 HL03743 NHLBI NIH HHS , K08 HL03743 NHLBI NIH HHS , K08 HL03743 NHLBI NIH HHS , NS24067 NINDS NIH HHS , K08 HL003743 NHLBI NIH HHS , K08 HL003743 NHLBI NIH HHS , K08 HL003743 NHLBI NIH HHS , K08 HL003743 NHLBI NIH HHS , K08 HL003743 NHLBI NIH HHS , K08 HL003743 NHLBI NIH HHS

Genes referenced:
Antibodies referenced:
Morpholinos referenced:

My Xenbase: [ Log-in / Register ]
version: [3.3.1]


Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556